Veridian Research

Compare · Research-Use-Only

Semax vs Selank

The two most-studied Russian-developed research peptides, frequently grouped together and rarely distinguished. Semax is an ACTH(4-7) fragment extended with Pro-Gly-Pro, studied mainly in neurotrophin expression and ischemia models. Selank is a tuftsin-derived heptapeptide investigated as a GABAergic modulator and enkephalinase inhibitor. Overlapping research framing, unrelated mechanisms.

Spec
Semax
Selank
Class
Synthetic peptide
Synthetic peptide
Molecular weight
813.9 g/mol
751.9 g/mol
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
Purity
99%+ HPLC
99%+ HPLC
Form
Lyophilized powder
Lyophilized powder
CAS number
80714-61-0
129954-34-3

Semax

Semax is a synthetic melanocortin derivative consisting of the ACTH(4-7) fragment extended at the C-terminus with the tripeptide Pro-Gly-Pro, an extension generally described as conferring resistance to enzymatic degradation relative to the unmodified ACTH fragment. Radioligand studies using tritium-labelled Semax identified specific, reversible, calcium-dependent binding sites in rat basal forebrain membranes with a dissociation constant of 2.4 nM, indicating a defined binding target, though the receptor entity has not been definitively identified. A principal downstream correlate is modulation of neurotrophin signalling: Semax induces rapid, region-specific changes in Bdnf and Ngf transcription in rat hippocampus, brainstem and cerebellum. In rodent cerebral ischemia models it activates transcription of neurotrophins and their Trk receptors selectively in ischemic cortex, whereas the effect of the Pro-Gly-Pro fragment alone is largely non-specific. Genome-wide transcriptional analysis after permanent middle cerebral artery occlusion shows that the dominant Semax-responsive gene set relates to the immune response, comprising over half of differentially expressed genes at 24 hours, with additional effects on genes governing endothelial migration and vasculogenesis. At the protein level in a transient occlusion model, Semax was associated with upregulation of active CREB in ischemic subcortical tissue and downregulation of MMP-9, c-Fos and active JNK in adjacent cortex. The mechanistic picture is therefore best characterized as pleiotropic transcriptional modulation of neurotrophic, inflammatory and vascular gene programs rather than a single defined receptor-effector pathway.

Selank

Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory tetrapeptide tuftsin, extended at the C-terminus with Pro-Gly-Pro. Two mechanistic lines dominate the literature. The first concerns the enkephalinergic system: Selank dose-dependently inhibits enzymatic hydrolysis of plasma enkephalin with a reported half-maximal inhibitory concentration of 15 micromolar, proving more potent in the same assay than the peptidase inhibitors bacitracin and puromycin, and the authors proposed that stabilization of endogenous enkephalins underlies its observed profile. The second concerns GABAergic modulation: radioligand-receptor analysis indicated that Selank affects GABA binding as a positive allosteric modulator in a subtype-selective, concentration-dependent manner, and that its joint action with benzodiazepines is non-cumulative and differs from either agent alone, suggesting binding sites that are distinct but possibly partially overlapping. Expression studies in rat frontal cortex found that Selank altered the expression of a large fraction of an 84-gene neurotransmission panel, with changes correlating positively with those produced by GABA itself. Notably, the corresponding in vitro experiment in IMR-32 neuroblastoma cells found no direct effect of Selank on GABAergic gene transcript levels, while co-administration with GABA suppressed GABA-induced expression changes, a result the authors interpreted as consistent with modulation of GABA-receptor interaction rather than direct transcriptional action. Selank has additionally been reported to influence Th1/Th2 cytokine balance and interleukin gene expression, consistent with its derivation from an immunopeptide. The mechanism should be regarded as incompletely characterized, and independent reviewers outside Russia have explicitly described the compound as poorly studied.

Other research peptide comparisons

Both compounds in stock at Veridian. 99%+ HPLC purity, same-day US shipping.

Browse all research peptides →